nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—Nitric oxide stimulates guanylate cyclase—NOS2—bile duct cancer	0.117	0.117	CbGpPWpGaD
Tofisopam—PDE10A—Nitric oxide stimulates guanylate cyclase—NOS2—bile duct cancer	0.0888	0.0888	CbGpPWpGaD
Tofisopam—PDE2A—Platelet homeostasis—GNAS—bile duct cancer	0.0625	0.0625	CbGpPWpGaD
Tofisopam—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—bile duct cancer	0.0524	0.0524	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—GNAS—bile duct cancer	0.0474	0.0474	CbGpPWpGaD
Tofisopam—PDE2A—Platelet homeostasis—NOS2—bile duct cancer	0.0457	0.0457	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—GNAS—bile duct cancer	0.0431	0.0431	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—NOS2—bile duct cancer	0.0346	0.0346	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—GNAS—bile duct cancer	0.0327	0.0327	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—GNAS—bile duct cancer	0.0279	0.0279	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—GNAS—bile duct cancer	0.0249	0.0249	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—NOS2—bile duct cancer	0.0204	0.0204	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—GNAS—bile duct cancer	0.0198	0.0198	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—GNAS—bile duct cancer	0.0193	0.0193	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—GNAS—bile duct cancer	0.014	0.014	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—HGF—bile duct cancer	0.0133	0.0133	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RNF43—bile duct cancer	0.0108	0.0108	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—GNAS—bile duct cancer	0.0106	0.0106	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—NRAS—bile duct cancer	0.0104	0.0104	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NOS2—bile duct cancer	0.0102	0.0102	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—HGF—bile duct cancer	0.0101	0.0101	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—KRAS—bile duct cancer	0.00897	0.00897	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—GNAS—bile duct cancer	0.00885	0.00885	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RNF43—bile duct cancer	0.00816	0.00816	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—GNAS—bile duct cancer	0.00804	0.00804	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NOS2—bile duct cancer	0.00775	0.00775	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—HRAS—bile duct cancer	0.00762	0.00762	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—GNAS—bile duct cancer	0.00671	0.00671	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—GNAS—bile duct cancer	0.00626	0.00626	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—GNAS—bile duct cancer	0.00609	0.00609	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—HGF—bile duct cancer	0.00596	0.00596	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NRAS—bile duct cancer	0.00585	0.00585	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TGFB1—bile duct cancer	0.00544	0.00544	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—KRAS—bile duct cancer	0.00504	0.00504	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RNF43—bile duct cancer	0.00495	0.00495	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFBR2—bile duct cancer	0.00492	0.00492	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RNF43—bile duct cancer	0.00481	0.00481	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—GNAS—bile duct cancer	0.00475	0.00475	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SMAD4—bile duct cancer	0.00466	0.00466	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NOS2—bile duct cancer	0.00457	0.00457	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TP53—bile duct cancer	0.00448	0.00448	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NRAS—bile duct cancer	0.00444	0.00444	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—HRAS—bile duct cancer	0.00428	0.00428	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TGFB1—bile duct cancer	0.00412	0.00412	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—GNAS—bile duct cancer	0.00406	0.00406	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—GNAS—bile duct cancer	0.00395	0.00395	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—KRAS—bile duct cancer	0.00382	0.00382	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFBR2—bile duct cancer	0.00373	0.00373	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—GNAS—bile duct cancer	0.00369	0.00369	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—GNAS—bile duct cancer	0.0036	0.0036	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—GNAS—bile duct cancer	0.00359	0.00359	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SMAD4—bile duct cancer	0.00353	0.00353	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TP53—bile duct cancer	0.00339	0.00339	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—NRAS—bile duct cancer	0.00336	0.00336	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—HRAS—bile duct cancer	0.00325	0.00325	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—EGFR—bile duct cancer	0.00306	0.00306	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—KRAS—bile duct cancer	0.00289	0.00289	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NRAS—bile duct cancer	0.00261	0.00261	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ERBB2—bile duct cancer	0.00261	0.00261	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—NRAS—bile duct cancer	0.00255	0.00255	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—HRAS—bile duct cancer	0.00246	0.00246	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TGFB1—bile duct cancer	0.00243	0.00243	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL6—bile duct cancer	0.00235	0.00235	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—EGFR—bile duct cancer	0.00232	0.00232	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFBR2—bile duct cancer	0.00226	0.00226	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—KRAS—bile duct cancer	0.00225	0.00225	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MMP9—bile duct cancer	0.00224	0.00224	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFBR2—bile duct cancer	0.0022	0.0022	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—KRAS—bile duct cancer	0.00219	0.00219	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GNAS—bile duct cancer	0.00218	0.00218	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SMAD4—bile duct cancer	0.00214	0.00214	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GNAS—bile duct cancer	0.00212	0.00212	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SMAD4—bile duct cancer	0.00208	0.00208	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TP53—bile duct cancer	0.002	0.002	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NRAS—bile duct cancer	0.00198	0.00198	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ERBB2—bile duct cancer	0.00198	0.00198	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—HRAS—bile duct cancer	0.00191	0.00191	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FAR2—bile duct cancer	0.00188	0.00188	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—HRAS—bile duct cancer	0.00186	0.00186	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—bile duct cancer	0.00184	0.00184	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EGFR—bile duct cancer	0.00181	0.00181	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—bile duct cancer	0.00178	0.00178	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KRAS—bile duct cancer	0.00171	0.00171	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—bile duct cancer	0.0017	0.0017	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—NRAS—bile duct cancer	0.00154	0.00154	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—bile duct cancer	0.00152	0.00152	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NRAS—bile duct cancer	0.0015	0.0015	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—NRAS—bile duct cancer	0.0015	0.0015	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HRAS—bile duct cancer	0.00145	0.00145	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EGFR—bile duct cancer	0.00141	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—bile duct cancer	0.0014	0.0014	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—bile duct cancer	0.00139	0.00139	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EGFR—bile duct cancer	0.00137	0.00137	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EGFR—bile duct cancer	0.00137	0.00137	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—KRAS—bile duct cancer	0.00133	0.00133	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KRAS—bile duct cancer	0.00129	0.00129	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—KRAS—bile duct cancer	0.00129	0.00129	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ERBB2—bile duct cancer	0.0012	0.0012	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB2—bile duct cancer	0.00116	0.00116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—bile duct cancer	0.00115	0.00115	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—HRAS—bile duct cancer	0.00113	0.00113	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HRAS—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—HRAS—bile duct cancer	0.0011	0.0011	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—bile duct cancer	0.00108	0.00108	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—bile duct cancer	0.00105	0.00105	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—bile duct cancer	0.00103	0.00103	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—bile duct cancer	0.000999	0.000999	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—IDH2—bile duct cancer	0.000916	0.000916	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NRAS—bile duct cancer	0.000911	0.000911	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NRAS—bile duct cancer	0.000886	0.000886	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—bile duct cancer	0.000847	0.000847	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGFR—bile duct cancer	0.00083	0.00083	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—bile duct cancer	0.000824	0.000824	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGFR—bile duct cancer	0.000807	0.000807	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000788	0.000788	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KRAS—bile duct cancer	0.000784	0.000784	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KRAS—bile duct cancer	0.000763	0.000763	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—bile duct cancer	0.000697	0.000697	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—bile duct cancer	0.000678	0.000678	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HRAS—bile duct cancer	0.000667	0.000667	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HRAS—bile duct cancer	0.000648	0.000648	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—bile duct cancer	0.000638	0.000638	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—bile duct cancer	0.000621	0.000621	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.00052	0.00052	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000404	0.000404	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—bile duct cancer	0.000217	0.000217	CbGpPWpGaD
